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Summary
Cytotoxic T lymphocytes (CTL) recognize short antigenic peptides associated with cell surface
class I major histocompatibility complex (MHC) molecules. This association presumably occurs
between newly synthesized class I MHC molecules and peptide fragments in a pre-Golgi
compartment . Little is known about the factors that regulate the formation of these antigenic
peptide fragments within the cell . To examine the role of residues within a core epitope and
in the flanking sequences for the generation and presentation of the newly synthesized peptide
fragment recognized by CD8+ CTL, we have mutagenized the coding sequence for the CTL
epitope spanning residues 202-221 in the influenza A/Japan/57 hemagglutinin (HA) . In this
study over 60 substitution mutations in the epitope were tested for their effects on target cell
sensitization using a cytoplasmic viral expression system. The HA202-221 site contains two
overlapping subsites defined by CTL clones 11-1 and 40-2 . Mutations in HA residues 204-213
or residues 210-219 often abolished target cell lysis by CTL clones 11-1 and 40-2, respectively .
Although residues outside the core epitope did not usually affect the ability to be lysed by CTL
clones, substitution of a Gly residue for Val-214 abolished lysis by clone 11-1 . These data suggest
that residues within a site that affect MHC binding and T cell receptor recognition appear to
play the predominant role in dictating the formation of the antigenic complex recognized by
CD8+ CTL, and therefore the antigenicity of the protein antigen presented to CD8+ T cells .
Most alterations in residues flanking the endogenously expressed epitope do not appreciably affect
the generation and recognition of the site.
C
D8+ CTL recognize nonnative fragments of proteins
associated withMHC class I molecules (1) . This associ-
ation presumably occurs between newly synthesized MHC
class I molecules and peptide fragments in a pre-Golgi com-
partment (2-4) . Peptide fragments are generated as a result
of protein fragmentation in the cytoplasm and possibly in
the endoplasmic reticulum (ER) . 1 Recent evidence suggests
that the peptide fragments associated withMHC class I mol-
ecules are 8-10 amino acids in length (5-8) and that MHC-
linked genes may encode products involved in the fragmen-
tation of cytosolic proteins (9-13) and transport of peptide
fragments from the cytoplasm to the ER . Although there
is an increasing body ofinformation on the structure ofMHC-
peptide complexes, little is known about the formation of
these antigenic fragments within the cell and the role of
residues within and surrounding an antigenic epitope in the
1 Abbreviations used in this paper : ds, double-stranded ; ER, endoplasmic
reticulum; HA, hemagglutinin ; NP, nucleoprotein .
generation of the endogenously processed product, its trans-
portation, and the formation of the complex between newly
synthesized endogenous peptide fragments andMHC class
I molecules (14, 15) .
The influenza A/Japan/57 virus contains an immuno-
dominant site that is recognized by CD8+ CTL in associa-
tion with the H-2 Kd molecule. This site encompasses two
distinct partially overlapping subsites recognized by different
subsets of Kd-restricted CTL (16) . These subsites span
hemagglutinin (HA) residues 204-213 (LYQNVGTYVS) and
210-219 (TYVSVGTSTL) as defined by expression of
minigenes encoding truncated portions of the 202-221 site
(Hahn et al ., manuscript in submitted for publication) and
synthetic peptides (Myers et al ., manuscript in preparation)
(see Fig . 1 a) . CTL clone 11-1 recognizes the HA204-213
site, whereas clone 40-2 recognizes the HA210-219 site .
To examine the importance ofresidues within the core epi-
tope and flanking site in the processing and presentation of
the newly synthesized peptide product, we have carried out
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20-amino acidHA202-221 site and expressed the mutant con-
structs using a double subgenomic Sindbis virus (dsSIN) ex-
pression vector (17) . Since theNH 2-terminal residues flank-
ing the 210-219 site, i.e., residues 202-209, lie in part within
the 204-213 site, we could simultaneously assess the effect
of mutations within the NH2-terminal site, i .e ., at residue
204-209, on recognition of the COOH-terminal 210-219
site. Likewise, mutations within the COOH-terminal site
would be assessed for their impact on the presentation of the
NH2-terminal site. We have found that mutations within
the coding sequence of an endogenous epitope affect T cell
recognition . With one exception alterations in flanking
residues do not substantially effect the formation of the epi-
tope recognized by CD8 * T cells . Thus, residues within a
site that affectMHC binding and TCR recognition appear
to play the predominant role in dictating the formation of
the antigenic complex recognized by CD8+ CTL and there-
fore the antigenicity of the protein antigen for CD8+ T
cells .
Materials and Methods
Saturation Mutagenesis.
￿
Two different parental HA202-221 con-
structs were utilized for saturation mutagenesis of the NH2- and
COON-terminal epitopes. For mutants 1-31, the parental construct
was a Met residue followed by HA residues 202-221 and 21 un-
related amino acids . For mutants 32-60, the parental construct began
with a Met residue followed by HA residues 198-221 and the same
21 unrelated amino acids. Each of these parental constructs gave
similar lysis values when tested with CTL clones 11-1 and 40-2 .
These minigenes were made by cloning appropriate synthetic double-
stranded (ds) oligonucleotide adaptors with flanking 5' Xbal and
3' BamHI cohesive ends into pH3'2J1, a phagemid shuttle vector
designed for constructing Sindbis virus recombinants (17) . To facili-
tate saturation mutagenesis of either the NH 2-terminal (HA202-
212) or the COOH-terminal epitope (HA211-221), silent changes
were used to introduce a KpnI site at residues 209 and 210 . For
saturation mutagenesis, the XbaI-KpnI or the KpnI-BamHI seg-
ments were replaced by ds oligonucleotides containing a mixture
ofbases (1.7 or2% contamination with the other threebases, respec-
tively) at all positions . Separate oligonucleotides were used to mu-
tate Gly-209. Pools of mutant plasmid DNAs were prepared (18),
and the ApaI-XhoI restriction fragment containing the Sindbis virus
subgenomic promoter, the HA minigenes, and the Sindbis virus
3' terminus was used to replace the corresponding region of the
full-length Sindbis vector cDNA clone (17) . Individual clones were
isolated, their sequences determined (18), and a subset was selected
for target cell sensitization studies . Infectious recombinant Sindbis
virus stocks of these mutants were rescued by in vitro transcrip-
tion of infectious RNA and transfection ofBHK21 cells (19) . Sub-
genomicRNA production has been analyzed for the negatives, or
surprising mutants .
Cell Lines and CTL Clones.
￿
The P815 (H-2d) mastocytoma
cells were maintained in DME supplemented with 10% (vol/vol)
FCS and 1% (wt/vol) glutamine . CTL clones 11-1 and 40-2 were
isolated CTL precursors primed with influenza A/Japan/305/57
virus and established as previously described (20) . They were pas-
saged weekly in the presence of irradiated influenza A/Japan/
305/57-infected splenocytes and a source of exogenousT cell growth
factor.
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Virus Stocks.
￿
Influenza A/Japan/305/57 virus(H2N2 subtype)
was grown in the allantoic cavity of 10-d-old chicken embryo and
stored as infectious allantoic fluid (21) . dsSIN stocks were produced
by hpofectin-mediated transfection of BHK-21 cells using 5' capped
RNA derived by SP6 RNA polymerase transcription of Xhol-
linearized plasmid templates (19). Culture supernatants were har-
vested at 24 h postinfection and aliquots stored at -80°C until
use . dsSIN virus titers were determined by plaque assay on
monolayers of chicken embryo fibroblasts .
CTLmediated Cytolysis Assay.
￿
The P815 (H-2d) cells were used
as target cells in a "Cr-release assay. 106 target cells were infected
for 1 h at 37°C with the various dsSIN recombinants (at 50
PFU/cell) and labeled with 150 p,Ci 5'Cr for 2 h at 37°C . After
washing to remove free label, target cells were incubated with CTL
clones for 6 h at 37°C as described previously (20) . The E/T ratio
was 5 :1 . The percentage of specific 5'Cr release was determined
by standard procedures (22) . Values for "Cr release were the mean
of quadruplicate samples and SDs were typically <5%.
Results and Discussion
Generation ofMutants in the HA202-221 Site by Saturation
Mutagenesis. The HA 202-221 site recognized by CD8+
CTL in association with the H-2 Kd molecule has been
mapped to two overlapping subsites spanning HA residues
204-213 (LYQNVGTYVS) and 210-219 (TYVSVGTSTL) by
analyzing minigenes encoding truncated portions of the
202-221 site. To investigate the role of individual amino acid
residues within the core epitope, as well as the flanking
residues, we have performed the saturation mutagenesis in
two overlappingCTL epitopes using ds oligonucleotides con-
taining a mixture of bases at all positions . Our strategy was
to express 42-46 amino acid-long peptides . The rationale was
to ensure a product of adequate length for effective proteo-
lytic processing and to avoid any interference due to variability
in length of the minigene product .
These mutations were rescued using infectious dsSIN recom-
binant . We have generated >70 mutants containing single
as well as multiple substitutions . P815 target cells expressing
the mutant epitopes were tested for recognition by two rep-
resentative Kd-restricted CD8+ CTL clones directed to
HA202-221 . One clone, 11-1, is directed to the NH2-ter-
minal 204-213 site, while the other clone, 40-2, is directed
to the COON-terminal 210-219 site .
Recognition of COOH-terminal Epitope Mutants by Clone
40-2. Mutations in the flanking residues 202-209 had little
effect on the recognition of the COOH-terminal 210-219
site by clone 40-2 (Fig . 2) . The first substitution to affect
T cell recognition was at position 210, where theThr-Asn
change resulted in diminished recognition of the 000H-
terminal210-219 site . A Thr-Gly substitution at this posi-
tion did not affect lysis by 40-2 . Mutations in residues 211-219
in most cases profoundly affected recognition ofthe product
by clone 40-2, while alterations in the COOH-terminal
flanking residues 220 Asn and 221 Lys had no effect on rec-
ognition . Taken together, these data suggest that mutations
in residues outside the minimal endogenous 210-219 epitope
have little effect on presentation and recognition of this en-
dogenous product .
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Figure 1 .
￿
Structure of the immunodominant HA202-221 epitope and
location of mutations within the epitope. (a) A schematic diagram ofim-
munodominant sites in the influenzaHA protein . The influenza A/Japan/57
HA contains two immunodominant sites restricted by class I Kd MHC
molecules. One site is located in the region spanning amino acid residues
202-221, and the other site corresponds to the HA523-545 region . The
analysis offine specificity ofthe HA202-221 site using several CTL clones
has shown that there are two overlapping subsites (16) . Solid lines repre-
sent the definition of the epitope by using the endogenously expressed
minigene products . (b) Mutations in the HA202-221 region . Mutations
generated by saturation mutagenesis were rescued by using the double sub-
genomic Sindbis expression vector (17) .
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523-545 The C001-1-terminal epitope (TYVSVGTSTL) has a
striking similarity to Kd-restricted peptide HLA A24
170-182 (RYLENGKETL), with Tyr (at position 2), Thr
(at position 9), and Leu (at position 10) believed to be pos-
sible anchor residues for Kd binding by peptide competition
studies (23) . The COOH-terminal peptide also contains the
proposed anchor residues of Tyr-211 at the second position
and Leu-219 at the 10th position to be critical for binding
to class I Kd molecules (23) . Substitutions at Tyr-211 abol-
ished lysis by 40-2. Substitution of Leu-219 with Trp abol-
ished T cell recognition, whereas replacement with Phe
resulted in a partial recognition by T cells . Indeed synthetic
peptides with a Tyr-Ala substitution at position 211 or
Leu-Ala substitution at position 219 only weakly bind Kd .
In contrast, synthetic peptides with substitutions at positions
212-218 efficiently bind the Kd molecule but vary in their
ability to be recognized by clone 40-2 (Myers et al ., manu-
script in preparation) . Therefore, the effect of a mutation in
the endogenous 210-219 product can be attributed to altera-
tion in either binding of the endogenous product to the Kd
molecule or recognition of the complex by antigen receptor
on clone 40-2 . In keeping with this concept, substitutions
at certain residues not directly involved in Kd binding, e.g.,
214 Val-Ile, 217 Ser-Ala, and 218 Thr-Ser or Lys, are toler-
ated in the endogenous product and recognized by 40-2 . Val-
214 can be replaced by Ile but not with Leu, Gly, Glu, or
Lys . Replacement of Ser-217 with Ala results in recognition
by 40-2 . It is surprising that Thr-218 could be replaced with
several different residues, including Ser, Lys, or Asn (albeit
with much less efficient lysis), given the data of Maryanski
et al . (23), which suggested that the Thr residue at the cor-
responding position in the HLAA24 epitope may be critical
for peptide-MHC interaction .
Recognition ofNH2-terminal Epitope Mutants by Clone 11-1 .
Comparable results were obtained when mutagenesis was car-
ried out in the NH2-terminal site recognized by clone 11-1
(Fig . 3) . Mutations in residues 202-203, which lie outside
of the minimum endogenous epitope, had no effect on rec-
Figure 2 .
￿
Recognition of mutant
HA peptides by the COOH-ter-
minal epitope-specific clone 40-2 .
Percentage value for relative lysis to
wild-type represents level of lysis in
mutant virus-infected target cells
divided by wild-type virus-infected
cells for CTL clone 40-2. Level of
lysis forparental construct was 80%
for clone 40-2 . As a negative con-
trol (C), SIN:027 recombinant ex-
pressing the H-2k-restricted epitope
ofHA (26) was used and the level
of nonspecific lysis observed for
SIN:027 was <5%. Cytotoxicity
assays, which included the entire set
of mutants, were repeated at least
three times and the relative values
were consistent . `Constructs that
contain more than one mutation .
RTLYQNVGTYVSVGTSTLNK RTLYQNVGTYVSVGTSTLNK
01 T
......... .. . .. .....
32 ---------D__-----___
02 S-----____-----____- 33 ---------H-----Z
03 C----____-----_____- 34 ---------H___D---___
04 G------__-----_____- 35 ----------L-----__--
05 -A--___-----___----- 36 ---------- I-------K_
06 -L-_____---_______-- 37 ----------G___IKQGIL
07 -K------------------ 38 -----------7,---_____
08 --F---___-----___--- 39 -----------C--____--
09 --W-__-----____----- 40 -----------P----K___
10 --W-L------____----- 41 ------------L_---___
11 ---D--__-----____--- 42 ------------G__----_
12 -_-N--___-----_____- 43 ------------ I-----K-
13 ___SE--______----___ 44 ------------g----C_Z
14 -_-IE-___-----____-_ 45 ------------&___K---
15 __-GE---__----_-____ 46 ------------KV__----
16 ----g-----____-----_ 47 -------------R_--VY_
17 ----L____----_______ 48 -------------- P---__
18 ----H_-__--___------ 49 ---------------A____
19 -----T--____------__ 50 ---------------- S-_-
20 -----K-__-----____-- 51 ---------------- N---
21 -----YL----___------ 52 ----------------K__-
22 -----TA-_------___-- 53 -----------------W__
23 ------g____---______ 54 -----------------FKR
24 ------G__------____- 55 ------------------D-
25 S-----G-__----_____- 56 ------------------Y-
26 -R----A_-----___---- 57 ------------------TT
27 -------S____-__---__ 58 -------------------R
28 -------c___-------__ 59 -------------------Q
29 -K-----C____------__ 60 -------------------Z
30
--------
N--___------
31 --------G----______-ognition of the endogenous product by clone 11-1 . On the
other hand, mutations in residues 204-213, which define the
minimal endogenous epitope, usually resulted in diminished
or abolished lysis by clone 11-1 .
The NH2-terminal epitope (LYQNVGTYVS) contains a
Kd-restricted peptide motif similar to that identified by se-
quence analysis of the HPLC-purified peptide population
bound to Kd molecules (7) . In these studies, the majority
of Kd-bound peptides appeared to be nonapeptides and con-
tained a nonrandom amino acid composition at each posi-
tion. For the second position, the predominant residue
identified was Tyr with significant levels of Phe, which has
a side chain similar to that ofTyr, and at position 9, the residues
preferred were Ile and Leu . At all other positions a larger,
but distinct, subset of residues was found . A comparison of
this motif with previously defined Kd-restricted epitopes (7)
indicated that, if aligned by the Tyr residue, most fit quite
well with the consensus Kd-restricted nonamer motif, indi-
cating that preferred residues, such as Tyr position 2 and Leu
or Ile at position 9, may represent critical anchor residues
for peptide-MHC interaction . The NH2-terminal epitope
fits this motif with Tyr-205 and Val-212 acting as anchors
at positions 2 and 9 . Parallel studies with synthetic peptides
suggest that the Tyr-205 and Val-212 are critical for peptide
binding to Kd . However, in this site other residues, with the
exception ofAsn 207 and Val 208, also appear to affect pep-
tide binding for Kd (Myers et al ., manuscript in preparation)
and therefore recognition by clone 11-1 . Substitution ofTyr-
205 (the proposed anchor residue) with Asp or Asn abol-
ished lysis completely. Substitution ofVal-212 (the proposed
anchor residue) by Ile or Gly abolished the lysis byCTL clone
11-1, whereas substitution with Leu allowed recognition by
11-1 . These results are interesting since the isolated endoge-
nous Kd-restricted peptides appear to predominantly utilize
Ile and Leu to anchor the residues to Kd molecules (7) . This
suggests that Val-212 may interact with the clone 11-1 TCR
as well as anchor the peptide to MHC molecules .
Replacement of Leu-204 by Phe is tolerated but results in
a decreased lysis by CTL clone 11-1 . Replacement with a
bulkier Trp residue abolished lysis, indicating that size ofthe
side chainmay be important for peptide interaction withMHC
or TCR . Asn-207 has been proposed to interact with the
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Figure 3 .
￿
Recognition ofmutant
HA peptides by theNH2-terminal
epitope-specific clone 11-1 . Percent
of relative lysis to wild type wascal-
culated as in Fig. 2 . Assays were
repeated at least three times and the
relative values were consistent . The
level of lysis for parental construct
was 50% for clone 11-1 and
nonspecific lysis for the negative
control, SIN:027, was 10% for CTL
clone 11-1 .
TCR based on sequence comparison of different influenza
virus strains (16), and Asn-207 could be replaced with Thr
but not with Lys . Val-208 could be replaced with by either
Ala or Gly but not with Glu, suggesting that either the size
or the hydrophobicity of the side chain could be important
at this position . Substitution of Gly-209 with Cys but not
with Ser was tolerated but led to less efficient lysis . This is
rather surprising given the structural similarity of Ser and
Cys, and suggests that stringent size constraints may exist
at this position . Studies with synthetic peptides suggests that
Gly-209 may contribute both toMHC interaction andTCR
contact . Ser-213 could be replaced with Ala and Cys but sub-
stitution with Pro resulted in a decreased lysis by clone 11-1 .
As observed for the residues flanking the 210-219 site, most
mutations in the residues flanking the 11-1 site at itsCOOH
terminus, i.e., residues 214-221 like the mutations in the
NH2-terminal 202 and 203 positions, had no effect on rec-
ognition of the site by clone 40-2 . A notable exception was
the minigene with the Gly change at position 214 (construct
42), which was not lysed by clone 11-1. Other substitutions
(e.g ., Va1-Leu, Ile, Glu, Lys) at this position were tolerated
(Fig . 3) .
The Val-Gly mutation at position 214 was the only al-
teration outside a minimal site of>50 mutants examined to
date that resulted in nearly complete loss of recognition of
the endogenous product . One explanation for this finding
is that the substitution of Gly at this position inhibits a pro-
cessing/presentation event necessary for the formation of the
peptide/Kd complex . Such an effect of flanking residues has
been proposed from studies on CD8+ T cell recognition of
a murine cytomegalovirus early gene product (14) . It is in-
teresting that Gly substitution at 214 led to the minimal en-
dogenous peptide followed by two Gly residues at itsCOOH
terminus . Double Gly residues at theCOOH-terminal border
of an epitope might play a negative role for antigen processing.
This hypothesis is currently being examined .
In this reportwe have examined the role of flanking residues
in the generation ofthe endogenous antigenic moiety recog-
nized by CD8+ CTL with the aim of analyzing the impact
of the surrounding amino acid residues on the immunoge-
nicity of a site recognized by CD8+ CTL . Mutations in the
HA204-213 region as expected affected the recognition by
CD8' T Cell Recognition Is Regulated Primarily within the Epitopeclone 11-1, which recognizes an epitope encompassing these
residues, while residues in the NH2- or COOH-terminal
flanking residues, with one notable exception, had no effect .
Similarly, only residues within HA210-219 were important
for lysis by clone 40-2 . At face value, our data suggest that
flanking residues per se may not play a determining role in
dictating the immunogenicity of a site within a protein . Ex-
cept for the 214 Vat-Gly change in each instance where a
mutation affectedT cell recognition of the 202-221 minigene
product, the mutation was in a residue within the putative
minimal endogenous epitope . On the other hand, the Val-Gly
mutation did not affect the generation of the 204-213 site
per se since another CD8+ clone 14-1 also directed to 204-
213 could recognize the gene product containing the Vat-Gly
mutation, albeit with a lower efficiency than the wild type
(Y S . Hahn, unpublished data) . Therefore, the Val-Gly al-
teration at position 214 did result in the formation ofan epi-
tope recognizable by CD8+ T cells . Even though clone 11-1
can recognize minigenes encoding only residues 204-213 or
204-212 (albeit with a lower efficiency) (Hahn et al ., manu-
script submitted for publication), we can not exclude the in-
triguing possibility that the actual endogenous site recog-
nized by clones 11-1 and 14-1 includes residue 214, and therefore
that clone 11-1 but not clone 14-1 is sensitive to Val-Gly
substitution at this position . Alternatively, substitution of
the Gly at position 214 may decrease the efficiency of trim-
ming of the endogenous product so that an 11-amino acid
peptide containing 214 Gly is associated with the Kd cleft .
This extended peptide would still be recognizable by clone
14-1 but not by clone 11-1 . These and other alternatives, e.g.,
effect ofVat-Gly substitution on peptide transport from the
cytoplasm to ER, are currently being examined .
These data support our earlier work, which showed that
reposition of the HA202-221 site in different positions along
the full-length HA polypeptide did not detectably influence
presentation ofthe antigenic moiety toMHC class I-restricted
T cells (15) . In the present report we have focused directly
on the role of flanking sequences outside the antigenic
site since in our earlier work two extra NH2-terminal and
COOH-terminal residues, i.e., Arg-202, Thr-203, Asn-220,
and Lys-221, were also included with the repositioned min-
imal endogenous peptide . Our data are consistent with the
study by Chimini et al . (24), which stated that CTL could
recognize target cells transfected with recombinant genes en-
coding the 13-merMHC class I-restricted T cell epitope in-
serted into the influenza virus nucleoprotein (NP) gene. Thus,
alteration of the flanking regions did not prevent antigen pro-
cessing and presentation . However, our results are in apparent
contrast to two other studies in which residues outside of
the antigenic site could alter processing and presentation of
antigen to class I-restricted T cells . One was the observation
by Del Val et al . (14) that an antigenic determinant from a
marine cytomegalovirus protein was not efficiently presented
when placed into certain regions of a heterologous protein .
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Hence, flanking residues can play a critical role in determining
the efficiency of antigen processing and presentation to the
Ld-restricted CTL . Flanking Gly residues and negatively
charged residues such as Asp were implicated as playing nega-
tive roles for efficient antigen presentation. The other obser-
vation was the report by Eisenlohr et al . (25) that the addi-
tion oftwo COOH-terminal residues corresponding to NP
residues Thr-157 and Gly-158 to a minigene encoding a nat-
urally processed determinant from influenza virus NP span-
ning amino acids 147-155 (TYQRTRALV) severely reduced
presentation of the endogenously produced peptide to Kd-
restricted CTL, whereas the minigene expressing residues
147-158 can efficiently sensitize target cells. However, its pre-
sentation was greatly enhanced by further extending to in-
clude all of the additional residues of NP (NP, Arg - ) . These
data suggest that Thr and Gly residues can negatively affect
the immunogenicity ofminimal determinants NP147-155 but
not the presentation of NP147-156 minigene product .
Several testable alternatives may account for these appar-
ently conflicting observations on the effects ofresidues flanking
core epitopes on recognition by CTL . A trivial possibility
is that, with the exception of the Gly substitution at Val-
214, the mutations examined in our study may not have in-
cluded those that hinder proteolytic processing and/or pep-
tide transport . Alternatively, the larger size of our minigene
construct (42-46 residues) may allow efficient proteolytic pro-
cessing and behave more like the full-length HA protein,
especially since the study of Eisenlohr et al. (25) suggests
that the negative effects of flanking sequences on the recog-
nition oftheir 10-32-residue minigene products can be reversed
by including all of the additional residues in NP. Another
possibility is that the expression levels of minigene products
by the Sindbis system may be too high to detect subtle differ-
ences in the efficiency ofpresentation and CTL recognition .
Finally, it may be relevant that CTL clones used for this study
have high-affinity TCRs and lyse target cells very efficiently,
even at ratios ofE/T cells as low as 1:1 . Although it is difficult
to correlate the level of specific Iysis by CTL with different
antigenic moieties, the level of specific lysis of target cells
expressing the HA minigene in our studies using an E/T
ratio of 5:1 is roughly equivalent to the recognition ofCMV
pp89 protein by specific CTL using anE/T ratio of 100:1(14) .
It is not yet clear that whether the processing of 42-46-
amino acid long peptides that we have tested in this study
occurs in the cytoplasm or whether they can be transported
to theERwithout any processing and further trimming occurs
after formation ofpeptide-MHC complexes . In any case, fu-
ture biochemical and cell biological investigations using defined
CTL epitopes with mutations blocking functional presenta-
tion (like the Gly-214 substitution) should help to delineate
discrete steps in the pathway as well as define the structural
determinants of the antigens that affect proteolysis, trans-
port, MHC association, and TCR recognition .References
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